Craft

Amyris

Stock Price

$0

2024-05-07

Market Capitalization

$744.6 K

2024-05-07

Revenue

$269.8 M

FY, 2022

Amyris Summary

Company Summary

Overview
Amyris is a biotechnology research company that develops sustainable ingredients for the clean health and beauty markets. It offers a clean chemistry solution for engineering the genetics of yeast strains and fermenting in sugarcane syrup.
Type
Public
Status
Active
Founded
2003
HQ
Emeryville, CA, US | view all locations
Website
https://amyris.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Han Kieftenbeld

    Han Kieftenbeld, Interim Chief Executive Officer and Chief Financial Officer

  • Christine Ofori

    Christine Ofori, Chief People Officer

  • Sola Biu

    Sola Biu, VP, Global Brand Marketing & Engagement

  • Deb Millard

    Deb Millard, Brand President, Stripes & Healthy Aging Brands

LocationsView all

2 locations detected

  • Emeryville, CA HQ

    United States

    5885 Hollis Street, Ste. 100

  • Sao Paulo, SP

    Brazil

    Rua John Dalton, 301 – Bloco B – Edificio 3 Condominio Techno Plaza

Amyris Financials

Summary Financials

Revenue (Q1, 2023)
$56.1M
Gross profit (Q1, 2023)
$5.0M
Net income (Q1, 2023)
($201.8M)
Cash (Q1, 2023)
$11.2M
EBIT (Q1, 2023)
($185.5M)
Enterprise value
$760.9M

Footer menu